CN Patent

CN102206216B — 作为蛋白质激酶抑制剂的吡咯并[2,3-b]吡啶衍生物

Assigned to Plexxikon Inc · Expires 2014-11-12 · 12y expired

What this patent protects

描述了具有蛋白激酶活性的式III化合物，以及用这样的化合物治疗与蛋白激酶的异常活性相关的疾病和病症的方法。

USPTO Abstract

描述了具有蛋白激酶活性的式III化合物，以及用这样的化合物治疗与蛋白激酶的异常活性相关的疾病和病症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN102206216B
Jurisdiction
CN
Classification
—
Expires
2014-11-12
Drug substance claim
No
Drug product claim
No
Assignee
Plexxikon Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.